Durvalumab vs Tamsulosin

## Durvalumab vs Tamsulosin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Tamsulosin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Tamsulosin**: Selective alpha-1A adrenergic receptor antagonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Tamsulosin — 10-13 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Tamsulosin — C20H28N2O5S.

**Molecular Weight**: Durvalumab — N/A; Tamsulosin — 408.5100 g/mol.

**Type**: Durvalumab — Antibody; Tamsulosin — Small molecule.